← 전체 보충제 목록

사위팔메토 (전립선)

Saw Palmetto (Prostate)

📑 PubMed 27편 ♂️ 남성

📚 관련 논문 (27편)

1.
Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study.
The Prostate 2026 PMID:41098072

1. Prostate. 2026 Feb;86(2):204-218. doi: 10.1002/pros.70071. Epub 2025 Oct 16. Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study. Bevilacqua G(1), Carino

2.
Multi-pharmacological treatment for young subfertile males with chronic prostatitis/chronic pelvic pain syndrome.
Investigative and clinical urology 2024 PMID:39505516

2. Investig Clin Urol. 2024 Nov;65(6):567-578. doi: 10.4111/icu.20240191. Multi-pharmacological treatment for young subfertile males with chronic prostatitis/chronic pelvic pain syndrome. Lee DH(1), Yu YD(2). Author information: (1)Department of Physiology, CHA University School of Medicine, Poc

3.
Beneficial effects of saw palmetto (Serenoa repens) fruit extract on the urinary symptoms of healthy Japanese adults with possible lower urinary tract symptoms: A randomized, double-blind, placebo-controlled study.
Nutrition and health 2025 PMID:39042923

3. Nutr Health. 2025 Sep;31(3):965-977. doi: 10.1177/02601060241265389. Epub 2024 Jul 23. Beneficial effects of saw palmetto (Serenoa repens) fruit extract on the urinary symptoms of healthy Japanese adults with possible lower urinary tract symptoms: A randomized, double-blind, placebo-controlle

4.
Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Nutrients 2022 PMID:35334848

4. Nutrients. 2022 Mar 11;14(6):1190. doi: 10.3390/nu14061190. Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Yamada S(1), Shirai M(1), Ono K(2), Kageyama S(3). Author informa

5.
The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial.
World journal of urology 2021 PMID:33452912

5. World J Urol. 2021 Sep;39(9):3489-3495. doi: 10.1007/s00345-020-03577-2. Epub 2021 Jan 16. The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial.

6.
Synergism of Specific Maca Phenotypes (Lepidium peruvianum) in Combination with Saw Palmetto (Serenoa repens) Extract for Chemoprevention of Prostate Cancer as Determined in In Vitro Cytotoxicity Assays on Human Epithelial and Prostate Cancer Cells.
Molecules (Basel, Switzerland) 2024 PMID:39683791

6. Molecules. 2024 Nov 28;29(23):5632. doi: 10.3390/molecules29235632. Synergism of Specific Maca Phenotypes (Lepidium peruvianum) in Combination with Saw Palmetto (Serenoa repens) Extract for Chemoprevention of Prostate Cancer as Determined in In Vitro Cytotoxicity Assays on Human Epithelial and

7.
Coagulopathy induced by saw palmetto: a case report.
Boletin de la Asociacion Medica de Puerto Rico 2009 PMID:20120986

7. Bol Asoc Med P R. 2009 Jul-Sep;101(3):48-50. Coagulopathy induced by saw palmetto: a case report. Villanueva S(1), González J. Author information: (1)Emergency Medicine Department, UPR School of Medicine, Puerto Rico Health Science Center, San Juan, Puerto Rico. Salvyem@gmail.com Saw palmett

8.
Serenoa repens (saw palmetto): a systematic review of adverse events.
Drug safety 2009 PMID:19591529

8. Drug Saf. 2009;32(8):637-47. doi: 10.2165/00002018-200932080-00003. Serenoa repens (saw palmetto): a systematic review of adverse events. Agbabiaka TB(1), Pittler MH, Wider B, Ernst E. Author information: (1)Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth

9.
Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
International journal of antimicrobial agents 2009 PMID:19394800

9. Int J Antimicrob Agents. 2009 Sep;34(3):283-4. doi: 10.1016/j.ijantimicag.2009.03.005. Epub 2009 Apr 25. Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patien

10.
Effects of D-004, a lipid extract from the royal palm (Roystonea regia) fruits, tamsulosin and their combined use on urodynamic changes induced with phenylephrine in rats.
Arzneimittel-Forschung 2008 PMID:18412021

10. Arzneimittelforschung. 2008;58(2):81-5. doi: 10.1055/s-0031-1296472. Effects of D-004, a lipid extract from the royal palm (Roystonea regia) fruits, tamsulosin and their combined use on urodynamic changes induced with phenylephrine in rats. Arruzazabala Mde L(1), Molina V, Más R, Carbajal D.

11.
Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration.
Journal of the Society for Integrative Oncology 2006 PMID:17022925

11. J Soc Integr Oncol. 2006 Fall;4(4):170-86. doi: 10.2310/7200.2006.016. Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration. Ulbricht C(1), Basch E, Bent S, Boon H, Corrado M, Foppa I, Hashmi S, Hammerness P, Kingsbury E, Smith M, Szapary P, Vora M,

12.
Herb-drug interactions. Interactions between saw palmetto and prescription medications.
Geriatrics 2005 PMID:16287339

12. Geriatrics. 2005 Nov;60(11):32, 34. Herb-drug interactions. Interactions between saw palmetto and prescription medications. Bressler R(1). Author information: (1)University of Arizona Health Sciences Center and the Sarver Heart Center, Tucson, USA. Patients over age 50 typically present wi

13.
Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
Clinical pharmacology and therapeutics 2003 PMID:14663456

13. Clin Pharmacol Ther. 2003 Dec;74(6):536-42. doi: 10.1016/j.clpt.2003.08.010. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Markowitz JS(1), Donovan JL, Devane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD. Author informat

14.
Long-term efficacy and safety of PRO 160/120 (a combination of sabal and urtica extract) in patients with lower urinary tract symptoms (LUTS).
Phytomedicine : international journal of phytotherapy and phytopharmacology 2003 PMID:12807343

14. Phytomedicine. 2003;10 Suppl 4:53-5. doi: 10.1078/1433-187x-00352. Long-term efficacy and safety of PRO 160/120 (a combination of sabal and urtica extract) in patients with lower urinary tract symptoms (LUTS). Bondarenko B(1), Walther C, Funk P, Schläfke S, Engelmann U. Author information: (

15.
What is saw palmetto used for, and does it interact with any medications?
Health news (Waltham, Mass.) 2000 PMID:10917733

15. Health News. 2000 Jun;6(6):10. What is saw palmetto used for, and does it interact with any medications? Gerber G(1). Author information: (1)University of Chicago School of Medicine, IL, USA. PMID: 10917733 [Indexed for MEDLINE]

16.
Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study.
Urologia internationalis 2015 PMID:25614155

12. Urol Int. 2015;94(2):187-93. doi: 10.1159/000366521. Epub 2015 Jan 23. Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study. Ryu YW(1), Lim SW, Kim JH, Ahn SH, Choi JD. Author informati

17.
Unsafe and potentially safe herbal therapies.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1999 PMID:10030529

26. Am J Health Syst Pharm. 1999 Jan 15;56(2):125-38; quiz 139-41. doi: 10.1093/ajhp/56.2.125. Unsafe and potentially safe herbal therapies. Klepser TB(1), Klepser ME. Author information: (1)Division of Clinical and Administrative Pharmacy, College of Pharmacy, The University of Iowa, Iowa City

18.
Is Serenoa repens effective for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? A systematic review and meta-analysis.
Asian journal of surgery 2022 PMID:35165019

25. Asian J Surg. 2022 Sep;45(9):1746-1747. doi: 10.1016/j.asjsur.2022.01.038. Epub 2022 Feb 12. Is Serenoa repens effective for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? A systematic review and meta-analysis. Lok W(1), Lin T(1), Cao D(1), Wei Q(2). Author inf

19.
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 2021 PMID:34933534

3. Arch Ital Urol Androl. 2021 Dec 21;93(4):475-480. doi: 10.4081/aiua.2021.4.475. Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials. Paulis G(1), Paulis A(2), Perletti G(3). Author information: (1)Department of Uro-Andrology, Castel

20.
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis.
Investigative and clinical urology 2021 PMID:34488251

45. Investig Clin Urol. 2021 Sep;62(5):520-534. doi: 10.4111/icu.20210254. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis. Trivisonno LF(1), Sgarbossa N(1), Alvez GA(2), Fieiras C(2), Escobar Liquitay CM

21.
Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
American journal of men's health 2020 PMID:32274957

36. Am J Mens Health. 2020 Mar-Apr;14(2):1557988320905407. doi: 10.1177/1557988320905407. Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Cai T(1)(2)(3), Cui Y(2)(4)(3), Yu S(5)(3), Li Q(6), Zhou Z(1)(2), Gao Z

22.
Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
European urology focus 2021 PMID:31952967

5. Eur Urol Focus. 2021 Mar;7(2):420-431. doi: 10.1016/j.euf.2020.01.002. Epub 2020 Jan 15. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Ra

23.
Benign prostate hyperplasia and nutrition.
Clinical nutrition ESPEN 2019 PMID:31451276

12. Clin Nutr ESPEN. 2019 Oct;33:5-11. doi: 10.1016/j.clnesp.2019.07.015. Epub 2019 Aug 12. Benign prostate hyperplasia and nutrition. Das K(1), Buchholz N(2). Author information: (1)U-merge Ltd. (Urology for Emerging Countries), London UK; Dept. of Urology, Bahrain Specialist Hospital, Bahrain

24.
Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene.
European review for medical and pharmacological sciences 2019 PMID:31002161

23. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3112-3120. doi: 10.26355/eurrev_201904_17595. Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene. Cannarella R(1), Calogero AE, Condorelli RA, Giacone F, Mongioi' LM, La Vignera S. Author inform

25.
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon(®) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.
BJU international 2018 PMID:29694707

16. BJU Int. 2018 Dec;122(6):1049-1065. doi: 10.1111/bju.14362. Epub 2018 Jun 6. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon(®) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis

26.
Serenoa repens for benign prostatic hyperplasia.
The Cochrane database of systematic reviews 2012 PMID:23235581

26. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3. Serenoa repens for benign prostatic hyperplasia. Tacklind J(1), Macdonald R, Rutks I, Stanke JU, Wilt TJ. Author information: (1)Center for Chronic Disease Outcomes Research (111-0), Minneapolis Vet

27.
[Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma].
Actas urologicas espanolas 2013 PMID:23058996

29. Actas Urol Esp. 2013 Feb;37(2):114-9. doi: 10.1016/j.acuro.2012.07.005. Epub 2012 Oct 8. [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma]. [Article in Spanish] Morán E(1), Budía A, Broseta E, Boronat F. Au

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.